IPO
Coverage Timeline
newest firstAll Coverage
IPO
Caris Leads a Wild Week for Recent IPO Stocks
Caris Life Sciences jumped 21.6% on a beat-and-raise quarter while BillionToOne fell 29.8% despite beating estimates, the sharpest split in the Renaissance IPO Index in weeks.
BRIEF
IPO
BillionToOne's Selloff Is a Warning for Biotech IPOs
IPO
BillionToOne's Selloff Is a Warning for Biotech IPOs
BillionToOne beat Q2 estimates by a wide margin and still fell nearly 30% because it reiterated rather than raised guidance -- a signal about how little room newly public companies have left to disappoint.
TRACE'S TAKE